PRA

NEUTRALM&A

ProAssurance Corporation

2026-02-23

Price

$24.40

-0.41%

Score3.8Watchlist

Signals3/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.8xvs 20d avg

Analysis

PRA is currently a 'Safety Play' disguised as a momentum breakout. The stock is pinned to a $25.00/share cash acquisition offer from The Doctors Company, expected to close in H1 2026. Today's Q4 earnings beat (EPS $0.82 vs $0.24 est) effectively removes 'Material Adverse Change' risk, solidifying the deal's completion. The 'Alpha Male' and 'Perfect Stack' signals are technically identifying the low-volatility, relentless bid from merger arbitrage desks absorbing shares just below the deal price, independent of the broader 'Caution' macro regime.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACKPANIC REVERSAL

Key Takeaways

**Merger Arbitrage Play:** The primary driver is the $25.00 cash buyout; upside is capped at ~2.5% (spread capture).
**Catalyst De-Risked:** Massive Q4 earnings beat confirms business stability, ensuring the acquisition proceeds without fundamental renegotiation.
**Regime Hedge:** In a 'Caution' market with Trade War headlines, PRA acts as a cash-equivalent store of value, uncorrelated to SPY or Tech beta.

← Back to 2026-02-23 View Full PRA History →Yahoo Finance &nearr;